As of 2025-05-17, the Relative Valuation of Interpace Biosciences Inc (IDXG) is 6.27 USD. This relative valuation is based on P/E multiples. With the latest stock price at 0.90 USD, the upside of Interpace Biosciences Inc based on Relative Valuation is 600.1%.
The range of the Relative Valuation is 2.91 - 10.70 USD.
| Range | Selected | |
| Trailing P/E multiples | 6.9x - 10.0x | 8.4x |
| Forward P/E multiples | 6.2x - 8.8x | 7.5x |
| Fair Price | 2.91 - 10.70 | 6.27 |
| Upside | 224.7% - 1095.6% | 600.1% |
| Date | P/E |
| 2025-05-14 | 0.78 |
| 2025-05-13 | 0.76 |
| 2025-05-12 | 0.76 |
| 2025-05-09 | 0.70 |
| 2025-05-08 | 0.61 |
| 2025-05-07 | 0.62 |
| 2025-05-06 | 0.66 |
| 2025-05-05 | 0.64 |
| 2025-05-02 | 0.63 |
| 2025-04-30 | 0.68 |
| 2025-04-29 | 0.59 |
| 2025-04-28 | 0.69 |
| 2025-04-25 | 0.61 |
| 2025-04-24 | 0.94 |
| 2025-04-23 | 0.94 |
| 2025-04-22 | 0.98 |
| 2025-04-21 | 0.98 |
| 2025-04-17 | 1.07 |
| 2025-04-16 | 1.07 |
| 2025-04-15 | 1.10 |
| 2025-04-14 | 1.09 |
| 2025-04-11 | 1.27 |
| 2025-04-10 | 1.20 |
| 2025-04-09 | 1.00 |
| 2025-04-08 | 0.94 |
| 2025-04-07 | 0.75 |
| 2025-04-04 | 0.84 |
| 2025-04-03 | 0.84 |
| 2025-04-02 | 0.80 |
| 2025-04-01 | 0.89 |
| 2025-03-31 | 0.88 |
| 2025-03-27 | 1.08 |
| 2025-03-26 | 1.08 |
| 2025-03-25 | 1.27 |
| 2025-03-24 | 1.24 |
| 2025-03-21 | 1.11 |
| 2025-03-20 | 1.11 |
| 2025-03-19 | 1.08 |
| 2025-03-17 | 1.08 |
| 2025-03-14 | 1.08 |
| 2025-03-13 | 1.08 |
| 2025-03-11 | 1.06 |
| 2025-03-10 | 1.10 |
| 2025-03-07 | 1.17 |
| 2025-03-06 | 1.17 |
| 2025-03-05 | 1.17 |
| 2025-03-04 | 1.08 |
| 2025-03-03 | 1.17 |
| 2025-02-28 | 1.17 |
| 2025-02-27 | 1.17 |